Physician profile
Mark A Prevost
NPI 1720086861
$54,977.84
in general payments reported to CMS, 2019-2025
27 companies · $6,520 in 2025
The $6,520 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $7,899 · 2021: $9,471 · 2022: $7,960 · 2023: $11K · 2024: $12K · 2025: $6,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Travel and Lodging: $9,002 · Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,500.00 |
| Travel and Lodging | $9,001.69 |
| Food and Beverage | $931.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nutech Spine, INC. | $41,688.86 | 2020-2025 | Sifix |
| Innovasis INC | $8,241.24 | 2023-2024 | |
| Alphatec Spine, INC | $1,778.53 | 2022 | |
| Precision Spine, INC. | $1,551.84 | 2024-2025 | |
| Nuvasive, INC. | $277.00 | 2020-2022 | |
| Depuy Synthes Sales INC. | $260.17 | 2019-2022 | |
| Carlsmed, INC. | $201.18 | 2024-2025 | Aprevo |
| Skeletal Dynamics INC | $187.84 | 2021 | |
| Providence Medical Technology, INC. | $152.94 | 2025 | |
| Boston Scientific Corporation | $106.29 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept |
| Globus Medical, INC. | $99.56 | 2025 | Senza |
| Horizon Therapeutics Plc | $60.40 | 2019-2020 | |
| Pfizer INC. | $53.29 | 2020-2025 | |
| Ethicon US, LLC | $37.56 | 2020-2024 | Surgiflo Hemostatic Matrix |
| Brainlab, INC. | $35.59 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $29.37 | 2025 | V.A.C. Veraflo, Prevena |
| Nevro Corp. | $28.38 | 2024 | Senza |
| Bioventus LLC | $26.49 | 2020 | |
| Orthofix Medical, INC. | $22.31 | 2025 | Cervical-Stim |
| Medtronic, INC. | $22.30 | 2025 | Unid_pass |
| Illuminoss Medical, INC. | $22.29 | 2021 | |
| Fidia Pharma USA INC. | $21.43 | 2020 | |
| Vericel Corporation | $18.18 | 2019 | |
| Radius Health, INC. | $15.26 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.09 | 2019 | |
| Amgen INC. | $13.68 | 2019 | |
| Smith+Nephew, INC. | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Prevost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.